MedeAnalytics International Appoints David Watson to Board of Directors

Kaiser Permanente CTO experience provides key expertise for U.K. market

LONDON, Feb. 19, 2010 — MedeAnalytics International, a leading provider of healthcare performance management solutions in the U.K., is pleased to announce the appointment of David A. Watson to its board of directors.

Watson currently holds the position of chief operating officer for MedeAnalytics in the U.S. and has more than 25 years of IT executive leadership experience. Prior to joining MedeAnalytics, he served at Kaiser Permanente as senior vice president and chief technology officer, where his responsibilities included technology long-term strategy, systems architecture and information security services across Kaiser’s hospitals, medical groups and insurance companies, serving nearly nine million members in nine states. Prior to Kaiser, Watson served in a variety of executive IT roles in the life sciences sector at Baxter Healthcare and at Allergan, Inc. Before his tenure in healthcare, he worked for recognized industry leaders such as Northrop Grumman and Mattel.

"Dave is a great addition to our U.K. subsidiary’s board of directors. His extensive industry experience and tenure at Kaiser Permanente are of great benefit to the company, as we continue to build the U.K. market and shareholder value," said MedeAnalytics Chief Executive Officer Mike Gallagher.

About MedeAnalytics
About MedeAnalytics Founded in 1994, MedeAnalytics enables healthcare organizations to improve clinical, financial and operational performance through on-demand analytics and client services. For the U.K. market, MedeAnalytics provides acute sector hospitals and foundation trusts with solutions to address Payment by Results (PbR), quality, innovation, productivity and prevention (QIPP), patient pathways, clinical quality, service line reporting, patient-level costing, staff productivity, regulatory compliance and enterprise performance management. For commissioners, the company provides solutions for world-class commissioning, vital signs, polyclinic planning and referral management. Worldwide, MedeAnalytics delivers business intelligence to over 800 healthcare organizations using a hosted, Software-as-a-Service (SaaS) model, which reduces up-front costs and enables rapid implementation and exceptional time-to-value. For more information, visit http://medeanalytics.co.uk.

###

<< Back to press releases